Bridgeway Capital Management LLC Acquires 145,000 Shares of The Beauty Health Company (NASDAQ:SKIN)

Bridgeway Capital Management LLC raised its stake in The Beauty Health Company (NASDAQ:SKIN - Free Report) by 13.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,211,600 shares of the company's stock after buying an additional 145,000 shares during the period. Bridgeway Capital Management LLC owned approximately 0.98% of Beauty Health worth $1,926,000 as of its most recent filing with the SEC.

Other hedge funds also recently bought and sold shares of the company. SG Americas Securities LLC grew its stake in Beauty Health by 38.2% in the fourth quarter. SG Americas Securities LLC now owns 35,290 shares of the company's stock valued at $56,000 after purchasing an additional 9,749 shares in the last quarter. Barclays PLC grew its holdings in shares of Beauty Health by 11.1% during the 4th quarter. Barclays PLC now owns 117,920 shares of the company's stock worth $187,000 after purchasing an additional 11,817 shares in the last quarter. Raymond James Financial Inc. bought a new stake in Beauty Health in the fourth quarter valued at about $25,000. Price T Rowe Associates Inc. MD grew its stake in shares of Beauty Health by 19.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 114,147 shares of the company's stock valued at $182,000 after purchasing an additional 18,400 shares during the period. Finally, Newman Dignan & Sheerar Inc. lifted its holdings in shares of Beauty Health by 39.1% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 71,144 shares of the company's stock valued at $113,000 after acquiring an additional 20,000 shares during the period. 93.26% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group lowered their price objective on Beauty Health from $1.50 to $1.25 and set a "hold" rating for the company in a research report on Monday, May 5th.

Beauty Health Price Performance

Beauty Health stock traded up $0.04 during mid-day trading on Thursday, reaching $1.52. 175,805 shares of the company were exchanged, compared to its average volume of 1,061,698. The company has a fifty day simple moving average of $1.19 and a 200-day simple moving average of $1.45. The firm has a market cap of $189.75 million, a PE ratio of -3.61 and a beta of 0.88. The company has a debt-to-equity ratio of 9.23, a current ratio of 6.56 and a quick ratio of 5.57. The Beauty Health Company has a 12 month low of $0.78 and a 12 month high of $2.85.

Beauty Health (NASDAQ:SKIN - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported ($0.08) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.05. Beauty Health had a negative net margin of 8.11% and a negative return on equity of 44.83%. The firm had revenue of $69.60 million for the quarter, compared to analyst estimates of $63.88 million. As a group, equities research analysts expect that The Beauty Health Company will post -0.25 earnings per share for the current fiscal year.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.